This Article Full Text Full Text (PDF) All Versions of this Article: 144/8/3683    most recent Author Manuscript (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Silvertown, J. D. Articles by Summerlee, A. J. S. Search for Related Content PubMed PubMed Citation Articles by Silvertown, J. D. Articles by Summerlee, A. J. S.

Adenovirus-Mediated Expression of Human Prorelaxin Promotes the Invasive Potential of Canine Mammary Cancer Cells

Department of Biomedical Sciences (J.D.S., A.J.S.S.), Ontario Veterinary College, University of Guelph, Guelph, Ontario N1G 2W1, Canada; and Millennium Pharmaceuticals Inc. (B.J.G.), Cambridge, Massachusetts 02139

Address all correspondence and requests for reprints to: Dr. Alastair J. S. Summerlee, Office of the Provost and Vice President (Academic), University of Guelph, University Centre, Fourth Floor, Guelph, Ontario, N1G 2W1, Canada. E-mail: a.summerlee{at}exec.uoguelph.ca.

This study reports the characterization of a recombinant adenoviral vector containing a tetracycline-regulatable promoter, driving the bicistronic expression of the human H2 preprorelaxin (hH2) cDNA and enhanced green fluorescent protein, via an internal ribosomal entry site. An hH2 ELISA was used to measure the secreted levels of recombinant hH2 in transfected canine (CF33.Mt) and human (MDA-MB-435) mammary cancer cell lines over a 6-d period; secreted peptide peaked on d 2 and 4 for the canine and human cell types, respectively. An unprocessed hH2 immunoreactive form of approximately 18 kDa was identified by Western blotting analysis and confirmed by mass spectrometry, suggesting that prorelaxin remains unprocessed in these cell types. The biological activity of the adenovirally expressed human prorelaxin was measured in the established human monocytic cell line THP-1 cAMP ELISA and in an in vitro Transwell cell migration system. Exogenous recombinant hH2 and adenovirally-mediated delivery of prorelaxin to CF33.Mt cells conferred a significant migratory action in the cells, compared with controls. Cell proliferation assays were performed to discount the possibility that the effect of relaxin was mitogenic. Thus, we have demonstrated that prorelaxin has the ability to facilitate cell migration processes exclusive of its ability to stimulate cell proliferation. In validating this adenovirus-based system, we have created a potential tool for further exploration of the physiology of relaxin in mammalian systems.

This article has been cited by other articles:

				S. Ganesh, M. Gonzalez Edick, N. Idamakanti, M. Abramova, M. VanRoey, M. Robinson, C.-O. Yun, and K. Jooss Relaxin-Expressing, Fiber Chimeric Oncolytic Adenovirus Prolongs Survival of Tumor-Bearing Mice Cancer Res., May 1, 2007; 67(9): 4399 - 4407. [Abstract] [Full Text] [PDF]

				S. Feng, I. U. Agoulnik, N. V. Bogatcheva, A. A. Kamat, B. Kwabi-Addo, R. Li, G. Ayala, M. M. Ittmann, and A. I. Agoulnik Relaxin Promotes Prostate Cancer Progression Clin. Cancer Res., March 15, 2007; 13(6): 1695 - 1702. [Abstract] [Full Text] [PDF]

				J. D. Silvertown, J. C. Symes, A. Neschadim, T. Nonaka, J. C. H. Kao, A. J. S. Summerlee, and J. A. Medin Analog of H2 relaxin exhibits antagonistic properties and impairs prostate tumor growth FASEB J, March 1, 2007; 21(3): 754 - 765. [Abstract] [Full Text] [PDF]

				J. D. Silvertown, J. S. Walia, A. J. Summerlee, and J. A. Medin Functional Expression of Mouse Relaxin and Mouse Relaxin-3 in the Lung from an Ebola Virus Glycoprotein-Pseudotyped Lentivirus via Tracheal Delivery Endocrinology, August 1, 2006; 147(8): 3797 - 3808. [Abstract] [Full Text] [PDF]

				S. Hombach-Klonisch, J. Bialek, B. Trojanowicz, E. Weber, H.-J. Holzhausen, J. D. Silvertown, A. J. Summerlee, H. Dralle, C. Hoang-Vu, and T. Klonisch Relaxin Enhances the Oncogenic Potential of Human Thyroid Carcinoma Cells Am. J. Pathol., August 1, 2006; 169(2): 617 - 632. [Abstract] [Full Text] [PDF]

				K. A. Figueiredo, A. L. Mui, C. C. Nelson, and M. E. Cox Relaxin Stimulates Leukocyte Adhesion and Migration through a Relaxin Receptor LGR7-dependent Mechanism J. Biol. Chem., February 10, 2006; 281(6): 3030 - 3039. [Abstract] [Full Text] [PDF]

				J. D. SILVERTOWN, R. FRASER, R. S. POTERSKI, B. GEDDES, and A. J.S. SUMMERLEE Central Effects of Long-Term Relaxin Expression in the Rat Ann. N.Y. Acad. Sci., May 1, 2005; 1041(1): 216 - 222. [Abstract] [Full Text] [PDF]

				P. L. RYAN, R. C. YOUNGBLOOD, J. HARVILL, and S. T. WILLARD Photonic Monitoring in Real Time of Vascular Endothelial Growth Factor Receptor 2 Gene Expression under Relaxin-Induced Conditions in a Novel Murine Wound Model Ann. N.Y. Acad. Sci., May 1, 2005; 1041(1): 398 - 414. [Abstract] [Full Text] [PDF]

				T KLONISCH, T. MUSTAFA, J. BIALEK, Y. RADESTOCK, H.-J. HOLZHAUSEN, H. DRALLE, C. HOANG-VU, and S. HOMBACH-KLONISCH Human Medullary Thyroid Carcinoma: A Source and Potential Target for Relaxin-Like Hormones Ann. N.Y. Acad. Sci., May 1, 2005; 1041(1): 449 - 461. [Abstract] [Full Text] [PDF]

				Y. RADESTOCK, C. HOANG-VU, and S. HOMBACH-KLONISCH Relaxin Downregulates the Calcium Binding Protein S100A4 in MDA-MB-231 Human Breast Cancer Cells Ann. N.Y. Acad. Sci., May 1, 2005; 1041(1): 462 - 469. [Abstract] [Full Text] [PDF]